SCOPUS 정보 검색 플랫폼

CONTINUUM Lifelong Learning in Neurology

Volumn 19, Issue 6, 2013, Pages 1615-1633

Inflammatory myopathies

(2) Amato, Anthony A a Greenberg, Steven A a

a MASSACHUSETTS GENERAL HOSPITAL (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; CLINICAL LABORATORY; DERMATOMYOSITIS; HISTOPATHOLOGY; HUMAN; IMAGING; IMMUNE MEDIATED NECROTIZING MYOPATHY; IMMUNOSUPPRESSIVE TREATMENT; INCLUSION BODY MYOSITIS; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYOPATHY; POLYMYOSITIS; REVIEW;

DERMATOMYOSITIS; HUMANS; MYOSITIS; MYOSITIS, INCLUSION BODY; POLYMYOSITIS;

EID: 84890528143 PISSN: 10802371 EISSN: 15386899 Source Type: Journal
DOI: 10.1212/01.CON.0000440662.26427.bd Document Type: Review

Times cited : (34)

References (16)

1
- 0030872207
- Idiopathic inflammatory myopathies
- Amato AA, Barohn RJ. Idiopathic inflammatory myopathies. Neurol Clin 1997;15(3):615-648.
- (1997) Neurol Clin , vol.15 , Issue.3 , pp. 615-648
- Amato, A.A.¹ Barohn, R.J.²

2
- 70349673434
- Evaluation and treatment of inflammatory myopathies
- Amato AA, Barohn RJ. Evaluation and treatment of inflammatory myopathies. J Neurol Neurosurg Psychiatry 2009;80(10): 1060-1068.
- (2009) J Neurol Neurosurg Psychiatry , vol.80 , Issue.10 , pp. 1060-1068
- Amato, A.A.¹ Barohn, R.J.²

3
- 70349658621
- Inclusion body myositis: Old and new concepts
- Amato AA, Barohn RJ. Inclusion body myositis: Old and new concepts. J Neurol Neurosurg Psychiatry 2009;80(11): 1186-1193.
- (2009) J Neurol Neurosurg Psychiatry , vol.80 , Issue.11 , pp. 1186-1193
- Amato, A.A.¹ Barohn, R.J.²

4
- 0029957253
- Inclusion body myositis: Clinical and pathological boundaries
- Amato AA, Gronseth GS, Jackson CE, et al. Inclusion body myositis: Clinical and pathological boundaries. Ann Neurol 1996; 40(4):581-586.
- (1996) Ann Neurol , vol.40 , Issue.4 , pp. 581-586
- Amato, A.A.¹ Gronseth, G.S.² Jackson, C.E.³

5
- 77953542744
- New York McGraw-Hill
- Amato AA, Russell J. Neuromuscular disease. New York: McGraw-Hill, 2008.
- (2008) Neuromuscular Disease
- Amato, A.A.¹ Russell, J.²

6
- 0016850495
- Polymyositis and dermatomyositis (first of two parts)
- Bohan A, Peters JB. Polymyositis and dermatomyositis (first of two parts). N Eng J Med 1975;292(7):344-347.
- (1975) N Eng J Med , vol.292 , Issue.7 , pp. 344-347
- Bohan, A.¹ Peters, J.B.²

7
- 0016638734
- Polymyositis and dermatomyositis (second of two parts)
- Bohan A, Peters JB. Polymyositis and dermatomyositis (second of two parts). N Eng J Med 1975;292(8):403-407.
- (1975) N Eng J Med , vol.292 , Issue.8 , pp. 403-407
- Bohan, A.¹ Peters, J.B.²

8
- 76649089945
- Immune-mediated necrotizing myopathy associated with statins
- Grable-Esposito P, Katzberg HD, Greenberg SA, et al. Immune-mediated necrotizing myopathy associated with statins. Muscle Nerve 2010;41(2):185-190.
- (2010) Muscle Nerve , vol.41 , Issue.2 , pp. 185-190
- Grable-Esposito, P.¹ Katzberg, H.D.² Greenberg, S.A.³

9
- 0028787389
- Inclusion body myositis and myopathies
- Griggs RC, Askanas V, DiMauro S, et al. Inclusion body myositis and myopathies. Ann Neurol 1995;38(5):705-713.
- (1995) Ann Neurol , vol.38 , Issue.5 , pp. 705-713
- Griggs, R.C.¹ Askanas, V.² Dimauro, S.³

10
- 0024340503
- Inclusion body myositis Observations in 40 patients
- Lotz BP, Engel AG, Nishino H, et al. Inclusion body myositis. Observations in 40 patients. Brain 1989;112(pt 3):727-747.
- (1989) Brain , vol.112 , Issue.PART 3 , pp. 727-747
- Lotz, B.P.¹ Engel, A.G.² Nishino, H.³

11
- 20944450759
- Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis
- Greenberg SA, Pinkus JL, Pinkus GS, et al. Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis. Ann Neurol 2005;57(5):664-678.
- (2005) Ann Neurol , vol.57 , Issue.5 , pp. 664-678
- Greenberg, S.A.¹ Pinkus, J.L.² Pinkus, G.S.³

12
- 84876491405
- Autoantibodies to cytosolic 5¶-nucleotidase 1A in inclusion body myositis
- Pluk H, van Hoeve BJ, van Dooren SH, et al. Autoantibodies to cytosolic 5¶-nucleotidase 1A in inclusion body myositis. Ann Neurol 2013;73(3):397-407.
- (2013) Ann Neurol , vol.73 , Issue.3 , pp. 397-407
- Pluk, H.¹ Van Hoeve, B.J.² Van Dooren, S.H.³

13
- 84876499456
- Cytosolic 5¶-nucleotidase 1A autoimmunity in sporadic inclusion body myositis
- Larman HB, Salajegheh M, Nazareno R, et al. Cytosolic 5¶-nucleotidase 1A autoimmunity in sporadic inclusion body myositis. Ann Neurol 2013;73(3):408-418.
- (2013) Ann Neurol , vol.73 , Issue.3 , pp. 408-418
- Larman, H.B.¹ Salajegheh, M.² Nazareno, R.³

14
- 84866329572
- Pathogenesis and therapy of inclusion body myositis
- Greenberg SA. Pathogenesis and therapy of inclusion body myositis. Curr Opin Neurol 2012;25(5):630-639.
- (2012) Curr Opin Neurol , vol.25 , Issue.5 , pp. 630-639
- Greenberg, S.A.¹

15
- 79953711138
- Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy
- Mammen AL, et al. Autoantibodies against 3-hydroxy-3-methylglutaryl- coenzyme A reductase in patients with statin-associated autoimmune myopathy. Arthritis Rheum 2011;63(3):713-721.
- (2011) Arthritis Rheum , vol.63 , Issue.3 , pp. 713-721
- Mammen, A.L.¹

16
- 84857887888
- Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effects
- Mammen AL, et al. Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effects. Arthritis Care Res (Hoboken) 2012;64(2): 269-272.
- (2012) Arthritis Care Res (Hoboken) , vol.64 , Issue.2 , pp. 269-272
- Mammen, A.L.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.